Accéder au contenu
Merck

Defining the proteolytic landscape during enterovirus infection.

PLoS pathogens (2020-10-01)
Mohsan Saeed, Sebastian Kapell, Nicholas T Hertz, Xianfang Wu, Kierstin Bell, Alison W Ashbrook, Milica Tesic Mark, Henry A Zebroski, Maxwell L Neal, Malin Flodström-Tullberg, Margaret R MacDonald, John D Aitchison, Henrik Molina, Charles M Rice
RÉSUMÉ

Viruses cleave cellular proteins to remodel the host proteome. The study of these cleavages has revealed mechanisms of immune evasion, resource exploitation, and pathogenesis. However, the full extent of virus-induced proteolysis in infected cells is unknown, mainly because until recently the technology for a global view of proteolysis within cells was lacking. Here, we report the first comprehensive catalog of proteins cleaved upon enterovirus infection and identify the sites within proteins where the cleavages occur. We employed multiple strategies to confirm protein cleavages and assigned them to one of the two enteroviral proteases. Detailed characterization of one substrate, LSM14A, a p body protein with a role in antiviral immunity, showed that cleavage of this protein disrupts its antiviral function. This study yields a new depth of information about the host interface with a group of viruses that are both important biological tools and significant agents of disease.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Acétonitrile, anhydrous, 99.8%
Sigma-Aldrich
Iodoacétamide, BioUltra
Sigma-Aldrich
Fluorure de phénylméthanesulfonyle, ≥98.5% (GC)
Sigma-Aldrich
Tris(2-carboxyéthyl)phosphine hydrochloride, BioUltra, ≥98% (NMR)
Sigma-Aldrich
Fluorure de 4-(2-aminoéthyl)-benzènesulfonyle hydrochloride, ≥97.0% (HPLC)
Sigma-Aldrich
Anti-Poliovirus 1 Antibody, clone 583-G8-G2-A4, ascites fluid, clone 583-G8-G2-A4, Chemicon®